On May 31, 2023 AAHI Presents Advancements In Vaccine Formulations and Methodology at Modern Vaccines Adjuvant Delivery Systems Conference 2023
On March 6, 2023 The Access to Advanced Health Institute Reports Encouraging Results of First-In-Human Trial of Its Temperature-Stable Tuberculosis Vaccine Candidate
On February 15, 2023 The Access to Advanced Health Institute Announces $3M Award to Develop an Intranasal Pan-Viral Countermeasure against Respiratory Viruses
On February 6, 2023 The Access to Advanced Health Institute Announces $9.9M Award to Develop a Nasal Spray Influenza RNA Vaccine Through Phase 1 Clinical Trials
On November 2, 2022 AAHI Develops Longer Lasting and Broadly Protective SARS-CoV-2 RNA Vaccine Candidate that is Stable at Room Temperature
On November 1, 2022 AAHI to Present Novel Applications of Its Unique Self-Amplifying RNA Vaccine Platform at the 10th International mRNA Health Conference